Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment

PHASE3CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Actinic Keratosis
Interventions
DRUG

SR-T100 gel

Patient will be instructed to self-apply approximately 0.3\~0.5g of SR-T100 gel on 25 cm squared treatment area (avoiding the periocular areas, lips, and nares) once daily with an occlusive dressing for 16 weeks treatment period.

DRUG

Vehicle gel

Patient wil be instructed to self-apply approximately 0.3\~0.5g of vehicle gel (without active ingredient)per total of 25 cm squared treatment area (avoiding the periocular areas, lips, and nares) once daily with an occlusive dressing for 16 weeks treatment period.

Trial Locations (6)

Unknown

Chiayi Chang Gung Memorial Hospital, Chiayi City

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

Kaohsiung Veterans General Hospital, Kaohsiung City

Chi Mei Medical Center YongKang, Tainan City

National Cheng Kung University Hospital, Tainan City

All Listed Sponsors
lead

G&E Herbal Biotechnology Co., LTD

INDUSTRY

NCT01493921 - Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment | Biotech Hunter | Biotech Hunter